Market Survey on Alcohol Use Disorder Treatment Market Covering Sales Outlook, Up-to-date Key Trends, Market Size and Forecast, Per Capita Expenditure, Company Share, Brand Share, Regulations, Reimbursement Scenario, Epidemiology, Procedure Numbers, and Pipeline Assessment
An In-depth Market Insights of Alcohol Use Disorder Treatment Market including Alcohol Abuse, Alcohol Dependence, Alcohol Addiction, and Alcoholism Covering 30+ Countries like United States, United Kingdom, Germany, France, Norway, Sweden, Saudi Arabia, United Arab Emirates, Japan, Korea, Australia, New Zealand, and Others
Alcohol Use Disorder Treatment Market Snapshot (2023 to 2033)
The global alcohol use disorder treatment market garnered a market value of US$ 700 million in 2023 and is expected to accumulate a market value of US$ 1,300 million by registering a CAGR of 6.4% in the forecast period 2023 to 2033. The rising incidence of alcohol abuse and binge drinking is predicted to fuel the industry. This disease makes no distinctions and may affect anybody, regardless of age or gender, creating a larger market for alcohol use disorder treatment.
Alcohol use disorder (AUD) is a common, chronic, relapsing illness defined by a reduced capacity to cease or regulate alcohol consumption in the face of considerable impairment, distress, or other negative effects. It is one of the most frequent drug use diseases in the world, affecting millions of people. Its clinical presentation variety reflects a complex interplay between numerous environmental, physiological, psychological, social, and biological elements that result in illness development and progression.
It is a very diverse disorder with complicated biology that affects people physically, emotionally, and socially. It is governed by multiple genes and gene-by-environment interactions, with a strong genetic effect predisposing certain people to acquire AUD. It is a prominent public health problem that causes enormous social impact and has a high morbidity and death rate. According to the WHO, about one-third of Americans consume enough alcohol to be classified at risk for alcohol addiction, and around three million fatalities, or 5.3% of all deaths, are recorded each year from alcohol consumption. On the plus side, there are several options for AUD treatment.
Hence, the growing incidence of addiction in the population, an expanding medicinal product pipeline, and the active participation of generic manufacturers in providing cheaper pharmaceuticals are the primary factors predicted to fuel the growth of the worldwide alcohol use disorder treatment market throughout the forecast period.
Data Points
Key Statistics
Expected Market Value (2023)
US$ 700 million
Anticipated Forecast Value (2033)
US$ 1,300 million
Projected Growth Rate (2023 to 2033)
6.4% CAGR
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Alcohol Use Disorder Treatment Demand Analysis (2018 to 2022) Vs Market Outlook (2023 to 2033)
The global demand for alcohol use disorder treatmentis projected to increase at a CAGR of 6.4% during the forecast period between 2023 and 2033, reaching a total of US$ 1,300 million in 2033, according to a report from Future Market Insights (FMI). From 2018 to 2022, sales witnessed significant growth, registering a CAGR of 5.5%.
The increased need for alcohol use disorder treatment is mostly due to the disease's global prevalence, with high prevalence observed in Eastern European nations, sections of South East Asia, and selected American countries. According to the Institute of Medicine, the prevalence of Fetal Alcohol Syndrome (FAS) in the USA in 1996 was between 0.5 and 3.0 instances per 1,000.
According to recent research from various US sites, the incidence of FAS was determined to be 2 to 7 instances per 1,000, with the prevalence of Fetal Alcohol Spectrum Disorders (FASD) estimated to be 20 to 50 cases per 1,000. Owing to the growing number of fatalities from alcohol-related liver illness is propelling market expansion throughout the assessment period.
Which are Some Prominent Drivers of Alcohol Use Disorder Treatment Market?
Growing Alcohol Abuse to Improve Maintenance and Performance
Over the last two decades, worldwide alcohol use disorder treatment has climbed threefold. Alcohol abuse is one of the significant risk factors for population health across the world.
According to the World Health Organization, excessive alcohol consumption accounts for 5.1% of the worldwide illness burden, with males accounting for 7.1% and females accounting for 2.2%. The worldwide treatment market is expected to generate considerable revenue over the projected period, owing to these factors.
Expanding the Number of Rehabilitation Centres to Drive the Market over the Assessment Period
Rising awareness regarding alcohol use disorder and an expanding number of rehabilitation centers are likely to drive market expansion in the approaching years. The worldwide market for alcohol use disorder treatment is expanding at an alarming rate. The rising usage of prescription pharmaceuticals is also considered contributing to the market's rise.
Increased government support, such as an increase in initiatives to improve consumer awareness about drug addiction is likely to drive this market throughout the forecast period. The continual development of novel therapies and pharmaceuticals for alcohol use disorder treatment is also expected to enhance this market throughout the forecast period.
Find your sweet spots for generating winning opportunities in this market.
Which are the Trough Areas faced by the Alcohol Use Disorder Treatment Market?
Reduced Knowledge of Viable Pharmacological Therapy to Stifle Market Growth
The core reason for AUD globally is a lack of resilience to overcome addiction, which leads to inconsistencies in treatment. Reduced knowledge of viable pharmacological therapy for AUD, particularly in emerging and underdeveloped nations, is a prominent factor limiting market expansion.
The availability of low-cost alternatives such as psychotherapy, counselling, and classic cold-turkey AUD therapies also has an impact on the rapid expansion. Alcohol abusers in India generally favour cultural de-addiction techniques such as Ayurveda and homoeopathy. Thus, the availability of numerous replacements for alcohol use disorder treatment is a key factor stifling market expansion. A lack of knowledge of alcohol dependency as a curable condition may limit the market for alcohol use disorder treatment.
Region-Wise Insights
How will the Alcohol Use Disorder Treatment Market Demand progress in the Asia Pacific?
Governments Initiatives to Widen Profit Margins
Asia Pacific is predicted to develop at the fastest rate during the forecast period. This is due to the fact that the governments of these regions are undertaking a number of programs to tackle drug addiction.
Owing to the large populations in countries such as China and India, Asia-Pacific is expected to be the fastest-expanding alcohol use disorder treatment market. As per Future Market Insights, the Asia Pacific is expected to grow at a CAGR of 6% during the forecast period 2023 to 2033.
Why North American Market is considered the Hotspot for Alcohol Use Disorder Treatment Market Players?
Soaring Number of Alcohol Drinkers to Accelerate Market Growth
North America had the largest share of the global alcohol use disorder treatment market in 2021. This is because the number of alcohol drinkers in the United States has increased and this disease makes no distinctions and may affect anybody, irrespective of age or gender, creating a larger market for alcohol use disorder treatment.
Rising usage of addiction treatment options, particularly for AUD, and a well-established healthcare infrastructure are likely to boost market possibilities. Combining alcohol with drugs leads to alcohol dependency, increasing the demand for AUD treatment. North America is expected to grow at a CAGR of 6.2% during the forecast period 2023 to 2033.
What makes Europe the Most Lucrative Market for Alcohol Use Disorder Treatment Market?
Burgeoning Rates of Alcohol Abuse fuelling the Growth of the Market
Europe dominates the alcohol use disorder treatment market owing to burgeoning rates of alcohol abuse, particularly in the United Kingdom. According to the World Health Organization (WHO), liver cirrhosis accounts for around 2% of all fatalities in European nations, whereas alcohol use accounts for approximately 1.5% of all deaths in England and Wales, according to figures released by the Office of National Statistics, United Kingdom Alcohol intake is also the leading cause of liver disease globally. Thus, owing to the aforementioned reasons, Europe is expected to grow at a CAGR of 6.3% during the forecast period 2023 to 2033.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need and save 40%!
Category-Wise Insights
Which is the Most Preferred Treatment Type in the Alcohol Use Disorder Treatment Market?
The Multidisciplinary Treatment Segment to enhance Sales Prospects
Addiction is a rising problem in today's culture, with over twenty million Americans suffering from at least one addiction. Understanding addiction allows people to better understand themselves and make more educated decisions about their health and well-being. Alcohol is among the most overused drugs in the world, with over 300 million people suffering from the illness, which has a negative impact on their overall health and well-being.
The use of multidisciplinary treatment in addiction tries to analyze mind functioning and optimize brain problems in order for people to operate better. This has made addiction therapy more comprehensive and dependable, with many strategies used. Various research demonstrating the benefits of these strategies in the treatment of addiction has rendered these therapies safe to employ.
Multidisciplinary addiction treatment attempts to have long-term and sustained benefits for those suffering from addiction. These therapies recognize the importance of personality in affecting everyday human interactions such as feelings, ideas, and sensations. Multidisciplinary treatment differs based on the individual and any influencing variables. Individuals suffering from mental illnesses, for example, respond differently to therapies. The complex approach required by the addiction dynamic necessitates the use of multidisciplinary treatment. Hence, the multidisciplinary treatment segment is likely to be the most preferred treatment type, accelerating the growth of the alcohol use disorder treatment market.
Which is the Most Lucrative Disorder Type in the Alcohol Use Disorder Treatment Market?
The Alcohol Abuse Segment to be Most Lucrative Disorder Type
Due to the changing lifestyles, more disposable money, and a larger young population in India, alcohol abuse is on the rise in emerging countries.
Alcohol is also a risk factor for mouth, throat, liver, and colon cancer. These will be the primary driving forces in the global alcohol use disorder treatment market.
Start-ups for Alcohol Use Disorder Treatment Market
Key start-up players in the alcohol use disorder treatment are offering new and innovative product lines to consolidate their market presence, these aforementioned start-ups have left no stone unturned. Some specific instances of key alcohol use disorder treatment start-ups are as follows:
Kinoxis Therapeutics, an Australian biotech business, is trying to create a variety of innovative medicinal molecules for the treatment of substance use disorders and other central nervous systems (CNS) problems. The firm intends to target the brain's oxytocin system in order to treat addiction to all main addictive chemical classes and to intervene at all phases of the addiction cycle. Kinoxis employs tiny chemicals that indirectly trigger the oxytocin pathway in the brain. The startup's primary candidate, KNX100, is now in preclinical testing.
Amygdala Neurosciences is a company located in the United States that is developing ANS-6637, a novel chemical entity that is a selective and reversible mitochondrial aldehyde dehydrogenase 2 (ALDH2) inhibitor. ANS-6637, which acts in the brain, reduces pathophysiologic dopamine surges while having no effect on basal dopamine. ANS-6637 may be effective in preventing drug-seeking behavior, desire, and relapse. ALDH2 inhibition decreased self-administration, and cue and drug-primed relapse in nicotine, alcohol, cocaine, heroin, methamphetamine, and binge eating models in preclinical investigations, while also displaying anti-anxiety characteristics in stress models. This product is currently in Phase II clinical trials.
Virtual Rehab is an Estonian MedTech firm that combines virtual reality technology with evidence-based treatments to promote mental health and well-being. This system combines virtual reality (VR), artificial intelligence (AI), and blockchain technology to treat pain, prevent substance use disorders, improve communication skills in autistic people, and rehabilitate repeat users. The startup now works with rehabilitation institutions, hospitals, and jail agencies, as well as other B2B industries.
Market Competition
Key players in the alcohol use disorder treatment market are Alkermes, Teva Pharmaceutical Industries Ltd., BioCorRx, Inc., Adial Pharmaceuticals, ADDEX THERAPEUTICS, Kinnov Therapeutics, Opiant Pharmaceuticals, Omeros Corporation, GlaxoSmithKline plc and Merck & Co. Inc.
Recent Developments:
In December 2022, BioCorRx Inc., a developer and provider of innovative treatment programmes for substance abuse and related disorders announced that it has partnered with Government Plus LLC, a leading provider of private sector healthcare to veterans, to expand its Beat Addiction Recovery Program across the country.
In November 2022, Teva Pharmaceutical Industries Ltd., announced a new cooperation with Rimidi, a leading clinical management platform developed to streamline clinical processes, improve patient experiences, and fulfil quality goals
In November 2022, Opiant Pharmaceuticals Inc. announced that it has entered into a final merger agreement with Indivior Inc, a subsidiary of Indivior PLC, to be acquired. According to the terms of the deal, Indivior will buy all of Opiant's existing shares for $20.00 per share in cash at closure, plus contingent value rights (CVRs) reflecting possible further payments of up to $8.00 per share over a seven-year period if accomplished.
In June 2022, Alkermes plc announced that it will begin accepting applications for its Alkermes Inspiration Grants® programme on June 15, 2022. This competitive grant programme, now in its sixth year, will award up to $500,000 in grants to nonprofit groups that seek to meet the needs of those living with addiction, major mental illness, or cancer.
Report Scope
Report Attribute
Details
Market Value in 2023
US$ 700 million
Market Value in 2033
US$ 1,300 million
Growth Rate
CAGR of 6.4% from 2023 to 2033
Base Year for Estimation
2022
Historical Data
2018 to 2022
Forecast Period
2023 to 2033
Quantitative Units
Revenue in US$ Million and CAGR from 2023 to 2033
Report Coverage
Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis
Segments Covered
Disorder Type
Treatment Type
Region
Regions Covered
North America
Latin America
Europe
Asia Pacific
Middle East and Africa
Key Countries Profiled
USA
Canada
Brazil
Mexico
Germany
United Kingdom
France
Spain
Italy
China
Japan
South Korea
India
Singapore
Thailand
Indonesia
Australia
New Zealand
GCC Countries
South Africa
Israel
Key Companies Profiled
Alkermes Plc.
Teva Pharmaceutical Industries Ltd.
BioCorRx, Inc.
Adial Pharmaceuticals Inc.
Addex Therapeutics Ltd.
Kinnov Therapeutics
Opiant Pharmaceuticals
Omeros Corporation
GlaxoSmithKline plc
Merck & Co. Inc.
Customization
Available Upon Request
Key Segments Profiled in the Alcohol Use Disorder Treatment Industry Survey
By Disorder Type:
Alcohol Abuse
Alcohol Dependence
Alcohol Addiction
Alcoholism
By Treatment Type:
Medication
Therapy
Multidisciplinary Treatment
By Region:
North America
Latin America
Europe
Asia Pacific
Middle East & Africa (MEA)
Frequently Asked Questions
Which country is set to register exponential growth in the Alcohol Use Disorder Treatment Market?
The United States may witness significant growth in the alcohol use disorder treatment market.
What drives sales of alcohol use disorder treatment?
The increasing awareness about the harmful effects of alcohol abuse and the rising demand for evidence-based treatment options are expected to drive alcohol use disorder treatment sales.
What key trends are driving the alcohol use disorder treatment market?
The increasing adoption of telemedicine and the development of new and innovative treatment options are some of the key trends driving the alcohol use disorder treatment market.
How was the historical performance of the alcohol use disorder treatment market?
The market recorded a CAGR of 5.5% in 2022.
What opportunities await for the market players?
Substantial investment in research and development, the development of new and innovative treatment options, and the expansion into new markets may provide growth prospects for the market players.
Table of Content
1. Executive Summary | Alcohol Use Disorder Treatment Market
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Disorder Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Disorder Type, 2018 to 2022
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Disorder Type, 2023 to 2033
5.3.1. Alcohol Abuse
5.3.2. Alcohol Dependence
5.3.3. Alcohol Addiction
5.3.4. Alcoholism
5.4. Y-o-Y Growth Trend Analysis By Disorder Type, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Disorder Type, 2023 to 2033
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Treatment Type
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By Treatment Type, 2018 to 2022
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Treatment Type, 2023 to 2033
6.3.1. Medication
6.3.2. Therapy
6.3.3. Multidisciplinary Treatment
6.3.4. Others
6.4. Y-o-Y Growth Trend Analysis By Treatment Type, 2018 to 2022
6.5. Absolute $ Opportunity Analysis By Treatment Type, 2023 to 2033
7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
7.1. Introduction
7.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022
7.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. Asia Pacific
7.3.5. Middle East & Africa (MEA)
7.4. Market Attractiveness Analysis By Region
8. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
8.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
8.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
8.2.1. By Country
8.2.1.1. USA
8.2.1.2. Canada
8.2.2. By Disorder Type
8.2.3. By Treatment Type
8.3. Market Attractiveness Analysis
8.3.1. By Country
8.3.2. By Disorder Type
8.3.3. By Treatment Type
8.4. Key Takeaways
9. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
9.2.1. By Country
9.2.1.1. Brazil
9.2.1.2. Mexico
9.2.1.3. Rest of Latin America
9.2.2. By Disorder Type
9.2.3. By Treatment Type
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Disorder Type
9.3.3. By Treatment Type
9.4. Key Takeaways
10. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. Germany
10.2.1.2. United Kingdom
10.2.1.3. France
10.2.1.4. Spain
10.2.1.5. Italy
10.2.1.6. Rest of Europe
10.2.2. By Disorder Type
10.2.3. By Treatment Type
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Disorder Type
10.3.3. By Treatment Type
10.4. Key Takeaways
11. Asia Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. China
11.2.1.2. Japan
11.2.1.3. South Korea
11.2.1.4. Singapore
11.2.1.5. Thailand
11.2.1.6. Indonesia
11.2.1.7. Australia
11.2.1.8. New Zealand
11.2.1.9. Rest of Asia Pacific
11.2.2. By Disorder Type
11.2.3. By Treatment Type
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Disorder Type
11.3.3. By Treatment Type
11.4. Key Takeaways
12. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. GCC Countries
12.2.1.2. South Africa
12.2.1.3. Israel
12.2.1.4. Rest of MEA
12.2.2. By Disorder Type
12.2.3. By Treatment Type
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Disorder Type
12.3.3. By Treatment Type
12.4. Key Takeaways
13. Key Countries Market Analysis
13.1. USA
13.1.1. Pricing Analysis
13.1.2. Market Share Analysis, 2022
13.1.2.1. By Disorder Type
13.1.2.2. By Treatment Type
13.2. Canada
13.2.1. Pricing Analysis
13.2.2. Market Share Analysis, 2022
13.2.2.1. By Disorder Type
13.2.2.2. By Treatment Type
13.3. Brazil
13.3.1. Pricing Analysis
13.3.2. Market Share Analysis, 2022
13.3.2.1. By Disorder Type
13.3.2.2. By Treatment Type
13.4. Mexico
13.4.1. Pricing Analysis
13.4.2. Market Share Analysis, 2022
13.4.2.1. By Disorder Type
13.4.2.2. By Treatment Type
13.5. Germany
13.5.1. Pricing Analysis
13.5.2. Market Share Analysis, 2022
13.5.2.1. By Disorder Type
13.5.2.2. By Treatment Type
13.6. UK
13.6.1. Pricing Analysis
13.6.2. Market Share Analysis, 2022
13.6.2.1. By Disorder Type
13.6.2.2. By Treatment Type
13.7. France
13.7.1. Pricing Analysis
13.7.2. Market Share Analysis, 2022
13.7.2.1. By Disorder Type
13.7.2.2. By Treatment Type
13.8. Spain
13.8.1. Pricing Analysis
13.8.2. Market Share Analysis, 2022
13.8.2.1. By Disorder Type
13.8.2.2. By Treatment Type
13.9. Italy
13.9.1. Pricing Analysis
13.9.2. Market Share Analysis, 2022
13.9.2.1. By Disorder Type
13.9.2.2. By Treatment Type
13.10. China
13.10.1. Pricing Analysis
13.10.2. Market Share Analysis, 2022
13.10.2.1. By Disorder Type
13.10.2.2. By Treatment Type
13.11. Japan
13.11.1. Pricing Analysis
13.11.2. Market Share Analysis, 2022
13.11.2.1. By Disorder Type
13.11.2.2. By Treatment Type
13.12. South Korea
13.12.1. Pricing Analysis
13.12.2. Market Share Analysis, 2022
13.12.2.1. By Disorder Type
13.12.2.2. By Treatment Type
13.13. Singapore
13.13.1. Pricing Analysis
13.13.2. Market Share Analysis, 2022
13.13.2.1. By Disorder Type
13.13.2.2. By Treatment Type
13.14. Thailand
13.14.1. Pricing Analysis
13.14.2. Market Share Analysis, 2022
13.14.2.1. By Disorder Type
13.14.2.2. By Treatment Type
13.15. Indonesia
13.15.1. Pricing Analysis
13.15.2. Market Share Analysis, 2022
13.15.2.1. By Disorder Type
13.15.2.2. By Treatment Type
13.16. Australia
13.16.1. Pricing Analysis
13.16.2. Market Share Analysis, 2022
13.16.2.1. By Disorder Type
13.16.2.2. By Treatment Type
13.17. New Zealand
13.17.1. Pricing Analysis
13.17.2. Market Share Analysis, 2022
13.17.2.1. By Disorder Type
13.17.2.2. By Treatment Type
13.18. GCC Countries
13.18.1. Pricing Analysis
13.18.2. Market Share Analysis, 2022
13.18.2.1. By Disorder Type
13.18.2.2. By Treatment Type
13.19. South Africa
13.19.1. Pricing Analysis
13.19.2. Market Share Analysis, 2022
13.19.2.1. By Disorder Type
13.19.2.2. By Treatment Type
13.20. Israel
13.20.1. Pricing Analysis
13.20.2. Market Share Analysis, 2022
13.20.2.1. By Disorder Type
13.20.2.2. By Treatment Type
14. Market Structure Analysis
14.1. Competition Dashboard
14.2. Competition Benchmarking
14.3. Market Share Analysis of Top Players
14.3.1. By Regional
14.3.2. By Disorder Type
14.3.3. By Treatment Type
15. Competition Analysis
15.1. Competition Deep Dive
15.1.1. Alkermes
15.1.1.1. Overview
15.1.1.2. Product Portfolio
15.1.1.3. Profitability by Market Segments
15.1.1.4. Sales Footprint
15.1.1.5. Strategy Overview
15.1.1.5.1. Marketing Strategy
15.1.2. Teva Pharmaceutical Industries Ltd.
15.1.2.1. Overview
15.1.2.2. Product Portfolio
15.1.2.3. Profitability by Market Segments
15.1.2.4. Sales Footprint
15.1.2.5. Strategy Overview
15.1.2.5.1. Marketing Strategy
15.1.3. BioCorRx, Inc.
15.1.3.1. Overview
15.1.3.2. Product Portfolio
15.1.3.3. Profitability by Market Segments
15.1.3.4. Sales Footprint
15.1.3.5. Strategy Overview
15.1.3.5.1. Marketing Strategy
15.1.4. Adial Pharmaceuticals
15.1.4.1. Overview
15.1.4.2. Product Portfolio
15.1.4.3. Profitability by Market Segments
15.1.4.4. Sales Footprint
15.1.4.5. Strategy Overview
15.1.4.5.1. Marketing Strategy
15.1.5. ADDEX THERAPEUTICS
15.1.5.1. Overview
15.1.5.2. Product Portfolio
15.1.5.3. Profitability by Market Segments
15.1.5.4. Sales Footprint
15.1.5.5. Strategy Overview
15.1.5.5.1. Marketing Strategy
15.1.6. Kinnov Therapeutics
15.1.6.1. Overview
15.1.6.2. Product Portfolio
15.1.6.3. Profitability by Market Segments
15.1.6.4. Sales Footprint
15.1.6.5. Strategy Overview
15.1.6.5.1. Marketing Strategy
15.1.7. Opiant Pharmaceuticals
15.1.7.1. Overview
15.1.7.2. Product Portfolio
15.1.7.3. Profitability by Market Segments
15.1.7.4. Sales Footprint
15.1.7.5. Strategy Overview
15.1.7.5.1. Marketing Strategy
15.1.8. Omeros Corporation
15.1.8.1. Overview
15.1.8.2. Product Portfolio
15.1.8.3. Profitability by Market Segments
15.1.8.4. Sales Footprint
15.1.8.5. Strategy Overview
15.1.8.5.1. Marketing Strategy
15.1.9. GlaxoSmithKline plc
15.1.9.1. Overview
15.1.9.2. Product Portfolio
15.1.9.3. Profitability by Market Segments
15.1.9.4. Sales Footprint
15.1.9.5. Strategy Overview
15.1.9.5.1. Marketing Strategy
15.1.10. Merck & Co. Inc.
15.1.10.1. Overview
15.1.10.2. Product Portfolio
15.1.10.3. Profitability by Market Segments
15.1.10.4. Sales Footprint
15.1.10.5. Strategy Overview
15.1.10.5.1. Marketing Strategy
16. Assumptions & Acronyms Used17. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
List of Tables
Table 1: Global Market Value (US$ Million) Forecast by Region, 2018 to 2033
Table 2: Global Market Value (US$ Million) Forecast by Disorder Type, 2018 to 2033
Table 3: Global Market Value (US$ Million) Forecast by Treatment Type, 2018 to 2033
Table 4: North America Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 5: North America Market Value (US$ Million) Forecast by Disorder Type, 2018 to 2033
Table 6: North America Market Value (US$ Million) Forecast by Treatment Type, 2018 to 2033
Table 7: Latin America Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 8: Latin America Market Value (US$ Million) Forecast by Disorder Type, 2018 to 2033
Table 9: Latin America Market Value (US$ Million) Forecast by Treatment Type, 2018 to 2033
Table 10: Europe Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 11: Europe Market Value (US$ Million) Forecast by Disorder Type, 2018 to 2033
Table 12: Europe Market Value (US$ Million) Forecast by Treatment Type, 2018 to 2033
Table 13: Asia Pacific Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 14: Asia Pacific Market Value (US$ Million) Forecast by Disorder Type, 2018 to 2033
Table 15: Asia Pacific Market Value (US$ Million) Forecast by Treatment Type, 2018 to 2033
Table 16: MEA Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 17: MEA Market Value (US$ Million) Forecast by Disorder Type, 2018 to 2033
Table 18: MEA Market Value (US$ Million) Forecast by Treatment Type, 2018 to 2033
Find your sweet spots for generating winning opportunities in this market.
List of Charts
Figure 1: Global Market Value (US$ Million) by Disorder Type, 2023 to 2033
Figure 2: Global Market Value (US$ Million) by Treatment Type, 2023 to 2033
Figure 3: Global Market Value (US$ Million) by Region, 2023 to 2033
Figure 4: Global Market Value (US$ Million) Analysis by Region, 2018-2033
Figure 5: Global Market Value Share (%) and BPS Analysis by Region, 2023 to 2033
Figure 6: Global Market Y-o-Y Growth (%) Projections by Region, 2023 to 2033
Figure 7: Global Market Value (US$ Million) Analysis by Disorder Type, 2018-2033
Figure 8: Global Market Value Share (%) and BPS Analysis by Disorder Type, 2023 to 2033
Figure 9: Global Market Y-o-Y Growth (%) Projections by Disorder Type, 2023 to 2033
Figure 10: Global Market Value (US$ Million) Analysis by Treatment Type, 2018-2033
Figure 11: Global Market Value Share (%) and BPS Analysis by Treatment Type, 2023 to 2033
Figure 12: Global Market Y-o-Y Growth (%) Projections by Treatment Type, 2023 to 2033
Figure 13: Global Market Attractiveness by Disorder Type, 2023 to 2033
Figure 14: Global Market Attractiveness by Treatment Type, 2023 to 2033
Figure 15: Global Market Attractiveness by Region, 2023 to 2033
Figure 16: North America Market Value (US$ Million) by Disorder Type, 2023 to 2033
Figure 17: North America Market Value (US$ Million) by Treatment Type, 2023 to 2033
Figure 18: North America Market Value (US$ Million) by Country, 2023 to 2033
Figure 19: North America Market Value (US$ Million) Analysis by Country, 2018-2033
Figure 20: North America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 21: North America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 22: North America Market Value (US$ Million) Analysis by Disorder Type, 2018-2033
Figure 23: North America Market Value Share (%) and BPS Analysis by Disorder Type, 2023 to 2033
Figure 24: North America Market Y-o-Y Growth (%) Projections by Disorder Type, 2023 to 2033
Figure 25: North America Market Value (US$ Million) Analysis by Treatment Type, 2018-2033
Figure 26: North America Market Value Share (%) and BPS Analysis by Treatment Type, 2023 to 2033
Figure 27: North America Market Y-o-Y Growth (%) Projections by Treatment Type, 2023 to 2033
Figure 28: North America Market Attractiveness by Disorder Type, 2023 to 2033
Figure 29: North America Market Attractiveness by Treatment Type, 2023 to 2033
Figure 30: North America Market Attractiveness by Country, 2023 to 2033
Figure 31: Latin America Market Value (US$ Million) by Disorder Type, 2023 to 2033
Figure 32: Latin America Market Value (US$ Million) by Treatment Type, 2023 to 2033
Figure 33: Latin America Market Value (US$ Million) by Country, 2023 to 2033
Figure 34: Latin America Market Value (US$ Million) Analysis by Country, 2018-2033
Figure 35: Latin America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 36: Latin America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 37: Latin America Market Value (US$ Million) Analysis by Disorder Type, 2018-2033
Figure 38: Latin America Market Value Share (%) and BPS Analysis by Disorder Type, 2023 to 2033
Figure 39: Latin America Market Y-o-Y Growth (%) Projections by Disorder Type, 2023 to 2033
Figure 40: Latin America Market Value (US$ Million) Analysis by Treatment Type, 2018-2033
Figure 41: Latin America Market Value Share (%) and BPS Analysis by Treatment Type, 2023 to 2033
Figure 42: Latin America Market Y-o-Y Growth (%) Projections by Treatment Type, 2023 to 2033
Figure 43: Latin America Market Attractiveness by Disorder Type, 2023 to 2033
Figure 44: Latin America Market Attractiveness by Treatment Type, 2023 to 2033
Figure 45: Latin America Market Attractiveness by Country, 2023 to 2033
Figure 46: Europe Market Value (US$ Million) by Disorder Type, 2023 to 2033
Figure 47: Europe Market Value (US$ Million) by Treatment Type, 2023 to 2033
Figure 48: Europe Market Value (US$ Million) by Country, 2023 to 2033
Figure 49: Europe Market Value (US$ Million) Analysis by Country, 2018-2033
Figure 50: Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 51: Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 52: Europe Market Value (US$ Million) Analysis by Disorder Type, 2018-2033
Figure 53: Europe Market Value Share (%) and BPS Analysis by Disorder Type, 2023 to 2033
Figure 54: Europe Market Y-o-Y Growth (%) Projections by Disorder Type, 2023 to 2033
Figure 55: Europe Market Value (US$ Million) Analysis by Treatment Type, 2018-2033
Figure 56: Europe Market Value Share (%) and BPS Analysis by Treatment Type, 2023 to 2033
Figure 57: Europe Market Y-o-Y Growth (%) Projections by Treatment Type, 2023 to 2033
Figure 58: Europe Market Attractiveness by Disorder Type, 2023 to 2033
Figure 59: Europe Market Attractiveness by Treatment Type, 2023 to 2033
Figure 60: Europe Market Attractiveness by Country, 2023 to 2033
Figure 61: Asia Pacific Market Value (US$ Million) by Disorder Type, 2023 to 2033
Figure 62: Asia Pacific Market Value (US$ Million) by Treatment Type, 2023 to 2033
Figure 63: Asia Pacific Market Value (US$ Million) by Country, 2023 to 2033
Figure 64: Asia Pacific Market Value (US$ Million) Analysis by Country, 2018-2033
Figure 65: Asia Pacific Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 66: Asia Pacific Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 67: Asia Pacific Market Value (US$ Million) Analysis by Disorder Type, 2018-2033
Figure 68: Asia Pacific Market Value Share (%) and BPS Analysis by Disorder Type, 2023 to 2033
Figure 69: Asia Pacific Market Y-o-Y Growth (%) Projections by Disorder Type, 2023 to 2033
Figure 70: Asia Pacific Market Value (US$ Million) Analysis by Treatment Type, 2018-2033
Figure 71: Asia Pacific Market Value Share (%) and BPS Analysis by Treatment Type, 2023 to 2033
Figure 72: Asia Pacific Market Y-o-Y Growth (%) Projections by Treatment Type, 2023 to 2033
Figure 73: Asia Pacific Market Attractiveness by Disorder Type, 2023 to 2033
Figure 74: Asia Pacific Market Attractiveness by Treatment Type, 2023 to 2033
Figure 75: Asia Pacific Market Attractiveness by Country, 2023 to 2033
Figure 76: MEA Market Value (US$ Million) by Disorder Type, 2023 to 2033
Figure 77: MEA Market Value (US$ Million) by Treatment Type, 2023 to 2033
Figure 78: MEA Market Value (US$ Million) by Country, 2023 to 2033
Figure 79: MEA Market Value (US$ Million) Analysis by Country, 2018-2033
Figure 80: MEA Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 81: MEA Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 82: MEA Market Value (US$ Million) Analysis by Disorder Type, 2018-2033
Figure 83: MEA Market Value Share (%) and BPS Analysis by Disorder Type, 2023 to 2033
Figure 84: MEA Market Y-o-Y Growth (%) Projections by Disorder Type, 2023 to 2033
Figure 85: MEA Market Value (US$ Million) Analysis by Treatment Type, 2018-2033
Figure 86: MEA Market Value Share (%) and BPS Analysis by Treatment Type, 2023 to 2033
Figure 87: MEA Market Y-o-Y Growth (%) Projections by Treatment Type, 2023 to 2033
Figure 88: MEA Market Attractiveness by Disorder Type, 2023 to 2033
Figure 89: MEA Market Attractiveness by Treatment Type, 2023 to 2033
Figure 90: MEA Market Attractiveness by Country, 2023 to 2033
